Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05504252
Title METIMMOX-2: Metastatic pMMR/MSS Colorectal Cancer - Shaping Anti-Tumor Immunity by Oxaliplatin (METIMMOX-2)
Acronym METIMMOX-2
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University Hospital, Akershus
Indications
Therapies
Age Groups: adult | senior
Covered Countries NOR

Additional content available in CKB BOOST